Anaplastic thyroid cancer
Anaplastic thyroid cancer | |
---|---|
Other names | Anaplastic thyroid carcinoma, ATC |
ENT surgery, oncology, endocrinology | |
Prevention | Use a thyroid guard when having any type of radiation, like X-rays or certain scans - even dental X-rays. |
Treatment | Chemotherapy, radiation therapy |
Anaplastic thyroid cancer (ATC), also known as anaplastic thyroid carcinoma, is an aggressive form of
ATC is an uncommon form of thyroid cancer only accounting for 1-2% of cases, but due to its high mortality, is responsible for 20-50% of deaths from thyroid cancer.[2] The median survival time after diagnosis is three to six months.[2] Some studies report that 10% to 15% survive more than 1 year; 3-year and 5-year survival is very rare.[3][4] It occurs more commonly in women than in men and is seen most commonly in people ages 40 to 70.[2]
Signs and symptoms
Anaplastic thyroid cancer typically manifests as a rapidly enlarging neck mass.
Causes
Risk factors include being over the age of sixty, a long-standing
Pathogenesis
Nearly half of ATC cases occur in the setting of coexisting differentiated thyroid cancer. This suggests that many ATC cases have dedifferentiated from differentiated thyroid cancer and, as a result, become more aggressive and difficult to treat. Differentiated thyroid cancer is seen coexisting with ATC on fine-needle aspiration biopsies in 20-50% of cases.[2]
Anaplastic tumors have a high
On
Diagnosis
Fine-needle aspiration is essential in order to obtain a sample of the thyroid tissue to allow for microscopic examination. This allows an experienced
ATC is divided into several different subclasses based on its microscopic characteristics. These include sarcomatoid, squamoid, osteoclastic, paucicellular, rhabdoid, and carcinomasarcoid variants.[2] As of 2019, despite the fact that these ATC subtypes are recognized, this classification has not led to differences in management.[2] ATC is always considered to be stage IV when it is diagnosed.[6]
There are no reliable laboratory tests for ATC.
Differential diagnosis
In addition to ATC, a rapidly enlarging neck mass prompts consideration of several other important diagnoses. These include other cancers such as primary
Prevention
This section is empty. You can help by adding to it. (June 2022) |
Management
ATC is considered an emergency cancer diagnosis since it poses a high risk of blocking the airway and/or esophagus due to its rapid growth in the neck, either of which can quickly cause a person's death by
Unlike its differentiated counterparts, anaplastic thyroid cancer is highly unlikely to be curable either by surgery or by any other treatment modality, and is in fact usually unresectable due to its high propensity for invading surrounding tissues.[7] A multidisciplinary team including an endocrine pathologist, head and neck surgeon, medical oncologist, radiation oncologist, endocrinologist, and a palliative care physician is essential for optimal management.[2] Palliative treatment consists of radiation therapy usually combined with chemotherapy.
The use of
Medications, such as
With the advent of molecular testing and next-generation sequencing, BRAF and MEK inhibitors are playing an increasing role in the management of patients with anaplastic thyroid cancer harboring such mutations. The combination of dabrafenib and trametinib has shown significant increases in overall survival and has been approved by the FDA. Another similar combination is vemurafenib and cobimetinib.
Immunotherapy is also starting to play an important role in anaplastic thyroid cancer management with several ongoing clinical trials demonstrating promising effects. Specific drugs being tested are atezolizumab, pembrolizumab, and spartalizumab, amongst others.
Combinatorial therapy that is molecular-based may lead to significant tumor regression, potentially making patients amenable to curative surgery.[10]
Post-operative radiotherapy
The role of external beam radiotherapy (EBRT) in thyroid cancer remains controversial and there is no level I evidence to recommend its use in the setting of differentiated thyroid cancers such as papillary and follicular carcinomas. Anaplastic thyroid carcinomas, however, are histologically distinct from differentiated thyroid cancers and due to the highly aggressive nature of ATC aggressive postoperative radiation and chemotherapy are typically recommended.
The National Comprehensive Cancer Network Clinical Practice Guidelines currently recommend that postoperative radiation and chemotherapy be strongly considered. No published randomized controlled trials have examined the addition of EBRT to standard treatment, namely surgery. Radioactive iodine is typically ineffective in the management of ATC as it is not an iodine-avid cancer.[11]
Imbalances in age, sex, completeness of surgical excision, histological type and stage, between patients receiving and not receiving EBRT, confound retrospective studies. Variability also exists between treatment and non-treatment groups in the use of radio-iodine and post-treatment
Some recent studies have indicated that EBRT may be promising, though the number of patients studies has been small.[12]
Clinical trials for investigational treatments are often considered by healthcare professionals and patients as first-line treatment.
Add-on therapy
In the absence of extracervical or unresectable disease, surgical excision should be followed by adjuvant radiotherapy. In the 18–24% of patients whose tumour seems both confined to the neck and grossly resectable, complete surgical resection followed by adjuvant radiotherapy and chemotherapy could yield a 75–80% survival at 2 years.
There are a number of clinical trials for anaplastic thyroid carcinoma underway or being planned.[13]
Prognosis
The overall
Treatment of anaplastic thyroid cancer is generally palliative in its intent due to its highly aggressive nature and nearly universal mortality. Larger tumors, distant metastases, acute obstructive symptoms, and leukocytosis portend a poorer prognosis. Death is attributable to upper airway obstruction and suffocation in half of patients, and to a combination of complications of local and distant disease, or therapy, or both in the remainder.
Anaplastic thyroid cancer is extremely aggressive; historically, in most cases death occurs in less than 1 year as a result of aggressive local growth and compromise of vital structures in the neck. ATC in most series has a median survival of 4 to 5 months from the time of diagnosis, with rare long-term survivors.[16]
Recent data however suggests that patients with BRAFV600E mutated disease, even if in an advanced stage, may have significantly better prognosis, as novel targeted therapies can extend tumor control considerably, while also leading to tumor burden decrease and potentially make patients candidates for surgery.[10] Recent advances show that using a combination of novel targeted therapies, immunotherapy, and surgery, 1 year and 2 year survival for anaplastic thyroid cancer patients have increased to 59% and 42%, respectively.[10]
Epidemiology
This section is empty. You can help by adding to it. (June 2022) |
History
This section is empty. You can help by adding to it. (June 2022) |
Research directions
This section is empty. You can help by adding to it. (June 2022) |
Notable cases
- William Rehnquist (1924–2005), Chief Justice of the United States (1986–2005)
- John Holt (1959–2013), NFL, Tampa Bay Buccaneers, Indianapolis Colts
- Kevin Towers (1961–2018), MLB executive[17]
- Guillermo Anderson (1962–2016), Honduran composer and singer
- Jeff Foskett(1956-2023), Member of Beach Boys
- Joe Plater. YouTube Vlogger.
References
- PMID 17098674.
- ^ S2CID 73415858.
- ^ Zivaljevic, Vladan, MD, PhD, Vlajinac, Hristina, et al. Case-Control Study of Anaplastic Thyroid Cancer: Papillary Thyroid Cancer Patients as Controls. Endocrinologist. 2010;20(6):308-311. doi:10.1097/TEN.0b013e3181fd02f2.
- ^ Rodriguez JM, Pinero A, Ortiz S, et al. Clinical and histological differences in anaplastic thyroid carcinoma. Eur J Surg. 2000;166:34-38.
- ^ Hu MI, Vassilopoulou-Sellin R, Lustig R, Lamont JP. "Thyroid and Parathyroid Cancers" Archived 2010-02-28 at the Wayback Machine in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds) Cancer Management: A Multidisciplinary Approach Archived 2013-10-04 at the Wayback Machine. 11 ed. 2008.
- ^ Harrison's Principles of Internal Medicine, 18th edition, p.2934
- S2CID 2087282.
- PMID 25396774.
- PMID 23721245.
- ^ a b c Maniakas A, Dadu R, et al., Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019 "JAMA Oncology",https://jamanetwork.com/journals/jamaoncology/article-abstract/2769127
- PMID 14524487.
- PMID 16360819.
- ^ "American Thyroid Association - Thyroid Clinical Trials". Archived from the original on 12 December 2007. Retrieved 2007-12-21.
- ^ cancer.org > Thyroid Cancer Archived 2013-10-18 at the Wayback Machine By the American Cancer Society. In turn citing: AJCC Cancer Staging Manual (7th ed).
- ^ ISBN 978-3-540-22309-2. (Note:Book also states that the 14% 10-year survival for anaplastic thyroid cancer was overestimated)
- ^ Kumar V, Abbas AK, Fausto N, and Mitchel RN, "Robbins basic Pathology", Saunders, 8th ed., 2007.
- ^ Rajan, Greg (October 29, 2017). "Astros manager A.J. Hinch stands up for friend Kevin Towers". Houston Chronicle.